TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OCGN

Ocugen Inc

Healthcare · Biotechnology

1.00$ +2.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow OCGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – -39,637.0% -34,206.3% -209,166.7% -2,414.8% -1,028.1% -1,039.3% -1,290.8%
– – – – – 142.2% 237.5% 999.1% 19.3% 11.7% 48.5% 54.1%
– – – – – 2,074.4% 1,534.9% 30,357.8% 423.7% 152.7% 183.2% 174.6%
– – – – – 13,631.6% 19,119.3% 33,616.9% 466.1% – – –
– – – – – -7,303.0% -2,814.4% 10,863.9% 369.6% -218.0% 90.4% -11.9%
– – – – – 69.1% 713.5% 4,096.9% 179.1% 173.6% 83.5% 4.2%
– – – – – -5,529.6% -713.5% -7,923.2% -682.0% 51.0% -83.5% -7.0%
– – – – – 15,955.0% – – – – – –
– – – – – -112.3% 84,521.4% 526,553.2% – – – –
– – – – – 12,412.0% -10,994.0% -43.6% 20.1% 8.3% 739.8% -22.7%
– – – – – 58,813.8% 73,514.0% 526,509.6% 2,390.5% 345.9% 1,599.5% 392.7%
– – – – – 13,647.2% 38,594.1% 309,419.7% -705.2% -631.2% 477.4% -904.9%
– – – – – -39,706.1% -34,919.9% -213,263.5% -2,593.9% -1,201.6% -1,122.7% -1,295.0%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?